Cann Group’s Debt Reset Opens a Path to Export Growth

Debt Forgiveness Drives Statutory Profit

Cann Group Limited (ASX:CAN) has reported a A$20.6 million statutory profit for FY2026, but the headline number comes with a large asterisk. A A$55.7 million gain from the settlement of A$70.6 million of National Australia Bank debt did most of the work, turning the previous year’s A$22.3 million loss into profit and lifting net assets from a A$2.8 million deficiency to A$29.0 million.

Strip out the debt forgiveness, creditor settlement, impairments and inventory write-downs, and Cann recorded a normalised loss after tax of A$14.7 million. That was still a 21% improvement on the comparable A$18.5 million loss, but it leaves the company some distance from recurring profitability.

Cash Burn Falls as Revenue Contracts

The more useful evidence of the reset sits in the cash flow and cost base. Operating cash outflow fell 86% to A$1.3 million, while operating expenses before depreciation and inventory write-downs declined 42% to A$12.8 million. Employee costs fell 26% to A$7.1 million and direct production costs dropped 55% to A$3.7 million. Cann says its second-half cost base points to an annualised FY2027 exit run-rate of about A$11.5 million.

That progress came alongside a 24% fall in revenue to A$8.6 million. Domestic dried-flower pricing remained under pressure, while the company chose margin and cash conversion over volume in low-priced bulk channels. The offset was international expansion: the United Kingdom contributed A$1.0 million in its first year, New Zealand generated A$0.4 million, and exports together accounted for 16% of revenue.

Refinancing Replaces NAB Exposure

The balance-sheet rescue reduced borrowings sharply, but it did not remove funding risk. Cann replaced the NAB facilities with a private-credit facility carrying A$15.4 million at year end, fixed interest of 12.5% and a maturity of 31 December 2027. The restructuring was supported by A$9.0 million of equity raisings, while shares on issue rose from 636.2 million to 1.66 billion during the year.

The remaining convertible notes were redeemed in full after year end using a A$2.0 million increase to the private-credit facility. That simplifies the capital structure, although the lender now holds the company’s secured debt relationship alone. Cann obtained a waiver for its minimum shareholder funds covenant at year end and was in breach of its minimum cash reserves test in August 2026, with a waiver continuing to apply.

Mildura Valuation Depends on Unfitted Capacity

Cann’s Mildura facility remains the central asset behind the recovery case. The site covers about 33,300 square metres under glass, including 6,600 square metres fitted out for production, while roughly 80% of its constructed EU-GMP certified area remains shell space. Production currently uses about 15% of the total footprint.

A A$19.0 million impairment was recognised at the half year. No further impairment was recorded at June 2026 after directors assessed the facility at a fair value less costs of disposal of A$56.1 million in their adopted mid-case, compared with a carrying amount of A$44.7 million. The valuation is a Level 3 estimate based partly on unobservable inputs, and the disclosed low case would imply an A$8.8 million shortfall. The auditor highlighted the valuation as a separate emphasis-of-matter issue.

Going Concern Remains a Live Issue

The auditor issued an unmodified opinion but drew attention to a material uncertainty related to going concern. Cann ended the year with just A$490,000 in cash, a net current asset deficiency of A$130,000 and continuing normalised losses. Directors said cash-flow forecasts support the going-concern basis, relying on the reduced cost base, export growth and access to the refinancing facility.

FY2027 therefore has a fairly precise test: export sales must become repeatable cash generation, while Mildura’s certified capacity must translate into contracted volume rather than remain an attractive valuation proposition. The company also intends to refinance the private-credit loan before December 2027. Until those two pieces move together, the statutory profit says less about Cann’s operating health than the A$1.3 million cash burn does.